Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
+1 212 318 2000
Europe, Middle East, & Africa
+44 20 7330 7500
+65 6212 1000
Supplements maker Martek Biosciences said Thursday it will sell most of the assets from a Kentucky plant to Alltech, an animal health company.
Under the agreement, Alltech will pay Martek $14 million over the next four years. Alltech will acquire the majority of the land and buildings at the Nicholasville, Ky., site, along with some equipment.
The transaction is expected to close by Nov. 30.
Shares of Martek Biosciences fell 2 cents Thursday to $22.84.